Event-Driven Stocks

4Front Ventures Corp.

Healthcare · Medicinal Chemicals & Botanical Products · SEC filings ↗ · Compare ⊕

Signs● 2 good● 5 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY23FY22FY21FY20FY19
Revenue$86.1M$95.7M$93.4M$46.6M$14.8M
Operating income−$20.8M−$15.0M−$14.1M−$32.6M−$179.8M
Net income−$91.6M−$46.9M$38.3M−$47.1M−$182.0M
Total assets$264.0M$344.7M$255.5M$204.8M$202.7M
Total liabilities$315.3M$316.4M$218.0M$162.6M$127.9M
Equity−$51.5M$28.3M$37.5M$42.2M$74.8M
EPS (diluted)—————
Shares out.669.5M627.8M566.2M——

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2023
Operating margin
−24.2%
Net margin
−106.4%
Return on equity
177.9%
Return on assets
−34.7%
Return on capital (ROCE)
−13.0%
Liabilities / assets
119.5%
Debt / equity
—
Book value / share
$-0.08
Revenue growth (YoY)
−10.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2023
Altman Z″ (distress)
-7.72distress
Accruals / assets
−34.0%clean
Beneish M-Score
-4.53normal
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
24
/ 100
Profitability 20Growth 0Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 5 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)